FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

F. Hoffmann-LaRoche Cymevene 500 mg Powder for Infusion Recall

Cymevene 500 mg Powder for Infusion, (ganciclovir), 50 mg/mL ganciclovir (reconstructed…

F. Hoffmann-LaRoche Ltd. · Basel, N/A

Risk level
Class II
Reported by FDA
Jan 2, 2013
Recall ID
D-105-2013
Check your lot numberHow we source this data

Summary

F. Hoffmann-LaRoche recalled Cymevene 500 mg Powder for Infusion starting Sep 5, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-105-2013 on Jan 2, 2013. Reason: Lack of Assurance of Sterility; container closure issues with the bulk batch. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility; container closure issues with the bulk batch.

Product description

Cymevene 500 mg Powder for Infusion, (ganciclovir), 50 mg/mL ganciclovir (reconstructed), Rx only, 10 mL vials, Roche Products Limited, Welwyn Garden City, AL7 1TW, United Kingdom

Lot numbers, UPCs & expiration codes

bulk lot N0019, Expiration Date: 11 2014 Warennummer: 10131968 Chargennummer:NXXXX 2000609D Finished product Lot N0019B01-N0019B12

Where it was sold

No product distributed in the USA. Bulk product distributed to Switzerland, with further distribution in Europe, Scandinavia, Korea.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-105-2013
Classification
Class II
Status
Terminated
Recall initiated
Sep 5, 2012
FDA report date
Jan 2, 2013
Quantity
42010 vials
Recall type
Voluntary: Firm initiated
Recalling firm
F. Hoffmann-LaRoche Ltd.

Original FDA data

Every field from FDA enforcement report D-105-2013, exactly as published.

Show all FDA fields
City
Basel
Status
Terminated
Country
Switzerland
Event ID
63656
Address
Grenzacherstrasse 124
Code information
bulk lot N0019, Expiration Date: 11 2014 Warennummer: 10131968 Chargennummer:NXXXX 2000609D Finished product Lot N0019B01-N0019B12
Report date
Jan 2, 2013
Product type
Drugs
Recall number
D-105-2013
Classification
Class II
Recalling firm
F. Hoffmann-LaRoche Ltd.
Product quantity
42010 vials
Termination date
Aug 29, 2013
Reason for recall
Lack of Assurance of Sterility; container closure issues with the bulk batch.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cymevene 500 mg Powder for Infusion, (ganciclovir), 50 mg/mL ganciclovir (reconstructed), Rx only, 10 mL vials, Roche Products Limited, Welwyn Garden City, AL7 1TW, United Kingdom
Distribution pattern
No product distributed in the USA. Bulk product distributed to Switzerland, with further distribution in Europe, Scandinavia, Korea.
Recall initiation date
Sep 5, 2012
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Dec 21, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-105-2013, published Jan 2, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls